Federal award
GENOVAC ANTIBODY DISCOVERY LLC
HT942524P0103
Contract
Obligated and Ceiling
- Obligated (net)
- $120,000.00
- Ceiling (potential value, not spending)
- $180,000.00
- Current value
- $120,000.00
- Gross positive obligations
- $160,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GENOVAC ANTIBODY DISCOVERY LLC · XLZUCKG5TEJ5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GENOVAC ANTIBODY DISCOVERY LLC · XLZUCKG5TEJ5
- Awarding agency
- Department of War · sub-agency 97DH · office HT9426
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- B537 · SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- HT942524P0103
- Award type code
- B
- Actions
- 5 · Sep 6, 2024 to Apr 8, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 8, 2026 | FY2026 | P00004 | M | $0.00 | — |
| Mar 11, 2026 | FY2026 | P00003 | M | $0.00 | — |
| Jun 25, 2025 | FY2025 | P00002 | C | $40,000.00 | — |
| Jun 5, 2025 | FY2025 | P00001 | D | −$40,000.00 | — |
| Sep 6, 2024 | FY2024 | 0 | — | $120,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.